PAPER Vicente MI, Costa PF, Lima PA

Galantamine inhibits slowly inactivating K+ currents with a dual dose-response relationship in differentiated N1E-115 cells and in CA1 neurones.

Eur J Pharmacol. 2010 May 25;634(1-3):16-25. PubMed: 20184872

PAPER Skrabana R, Dvorsky R, Sevcik J, Novak M

Monoclonal antibody MN423 as a stable mold facilitates structure determination of disordered tau protein.

J Struct Biol. 2010 Feb 23; PubMed: 20184958

PAPER Dobos N, Korf J, Luiten PG, Eisel UL

Neuroinflammation in Alzheimer's disease and major depression.

Biol Psychiatry. 2010 Mar 15;67(6):503-4. PubMed: 20185031

PAPER Calciano MA, Zhou W, Snyder PJ, Einstein R

Drug treatment of Alzheimer's disease patients leads to expression changes in peripheral blood cells.

Alzheimers Dement. 2010 Sep;6(5):386-93. PubMed: 20185375

PAPER Silverstein NM, Wong CM, Brueck KE

Adult day health care for participants with Alzheimer's disease.

Am J Alzheimers Dis Other Demen. 2010 May;25(3):276-83. PubMed: 20185401

PAPER Calissano P, Matrone C, Amadoro G

Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease.

Dev Neurobiol. 2010 Apr;70(5):372-83. PubMed: 20186703

PAPER Lim YA, Rhein V, Baysang G, Meier F, Poljak A, Raftery MJ, Guilhaus M, Ittner LM, Eckert A, Götz J

Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction.

Proteomics. 2010 Apr;10(8):1621-33. PubMed: 20186753

PAPER Sozio P, D'Aurizio E, Iannitelli A, Cataldi A, Zara S, Cantalamessa F, Nasuti C, Di Stefano A

Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity.

Arch Pharm (Weinheim). 2010 Mar;343(3):133-42. PubMed: 20186865

PAPER Guo J, Sun Z, Xiao S, Liu D, Jin G, Wang E, Zhou J

Proteomic analysis of the cerebrospinal fluid of Parkinson's disease patients.

Cell Res. 2009 Dec;19(12):1401-3. PubMed: 19949427

PAPER Sherrod RA, Collins A, Wynn S, Gragg M

Dissecting dementia, depression, and drug effects in older adults.

J Psychosoc Nurs Ment Health Serv. 2010 Jan;48(1):39-47. PubMed: 20102132

PAPER Ostrovskaia RU, Tsaplina AP, Vakhitova Iu, Salimgareeva MK, Iamidanov RS

[Effect of the novel nootropic and neuroprotective dipeptide noopept on the streptozotocin-induced model of sporadic Alzheimer disease in rats].

Eksp Klin Farmakol. 2010 Jan;73(1):2-6. PubMed: 20184279

PAPER Hayashi Y, Ishida Y, Inoue T, Udagawa M, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Sameshima T, Kawahara T, Goto I, Shudo K, Kurayama S, Nakamura J, Okahara K, Mitsuyama Y

Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):541-5. PubMed: 20184936

PAPER Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, Mintun MA

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.

Ann Neurol. 2010 Jan;67(1):122-31. PubMed: 20186853

PAPER Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y

Evidence in favor of Braak staging of Parkinson's disease.

Mov Disord. 2010;25 Suppl 1:S78-82. PubMed: 20187227

SNX17

ANTIBODY polyclonal manufacturer Cat# ab67599 immunogen = full length protein, corresp. to aa1-470 of human SNX17 liquid, PBS, no preservative, protein A purified Sorting Nexin 17 IgG Protein Trafficking Abcam Mouse Human SNX17 http://alzforum.org/res/com/ant/defa